Document is current
Any future updates will be listed below
-
Authors
Harsini, Sara
Wilson, Don
Saprunoff, Heather
Allan, Hayley
Gleave, Martin
Goldenberg, Larry
Chi, Kim N.
Kim-Sing, Charmaine
Tyldesley, Scott
Bénard, François https://orcid.org/0000-0001-7995-3581
-
Funding
Funding for this research was provided by:
BC Cancer Foundation (BC Cancer Foundation)
Terry Fox Research Institute (Terry Fox Research Institute)
BC Leadership Chair in Functional Cancer Imaging (BC Leadership Chair in Functional Cancer Imaging)
Canadian Institutes of Health Research (FDN-148465)
- License Information
-
More Information
Article History
Received: 2 November 2022
Accepted: 5 March 2023
First Online: 17 March 2023
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the UBC/BC Cancer Research Ethics Board and by Health Canada (ethics code H16-01551).
: Not applicable.
: The authors report no conflict of interest with the material presented in this study. FB is co-founder, director, consultant, and shareholder of Alpha-9 Theranostics, a radiopharmaceutical company, outside the submitted work.
